Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc R Mansour

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|November 17, 2006
A role for aberrant Notch signaling in acute myeloid leukemia?Marc R Mansour
Expert Review of Hematology|November 19, 2010
Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphomaMarc R Mansour
Ebiomedicine|December 23, 2021
Therapeutic targeting of "undruggable" MYCVictor Llombart, Marc R Mansour
Blood|September 26, 2024
T-ALL and T-LBL: a notch apartRachael Pocock, Marc R Mansour
Disease Models & Mechanisms|November 28, 2019
The role of noncoding mutations in blood cancersSunniyat Rahman, Marc R Mansour
Haematologica|December 18, 2023
ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemiaJoana R Costa, Marc R Mansour
Cancer Cell|November 19, 2011
Discovery of a secreted tumor suppressor provides a promising therapeutic strategy for follicular lymphomaMarc R Mansour, A Thomas Look
British Journal of Haematology|May 4, 2021
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemiaRachael Pocock, Nadine Farah, Simon E Richardson, et al.
Blood|March 11, 2014
Notch signaling: switching an oncogene to a tumor suppressorCamille Lobry, Philmo Oh, Marc R Mansour, et al.
Leukemia|November 18, 2023
Monitoring clone dynamics and reversibility in clonal haematopoiesis and myelodysplastic neoplasm associated with PARP inhibitor therapy-a role for early monitoring and interventionEllen Nuttall Musson, Rowan E Miller, Marc R Mansour, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|November 17, 2006
A role for aberrant Notch signaling in acute myeloid leukemia?Marc R Mansour
Expert Review of Hematology|November 19, 2010
Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphomaMarc R Mansour
Ebiomedicine|December 23, 2021
Therapeutic targeting of "undruggable" MYCVictor Llombart, Marc R Mansour
Blood|September 26, 2024
T-ALL and T-LBL: a notch apartRachael Pocock, Marc R Mansour
Disease Models & Mechanisms|November 28, 2019
The role of noncoding mutations in blood cancersSunniyat Rahman, Marc R Mansour
Haematologica|December 18, 2023
ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemiaJoana R Costa, Marc R Mansour
Cancer Cell|November 19, 2011
Discovery of a secreted tumor suppressor provides a promising therapeutic strategy for follicular lymphomaMarc R Mansour, A Thomas Look
British Journal of Haematology|May 4, 2021
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemiaRachael Pocock, Nadine Farah, Simon E Richardson, et al.
Blood|March 11, 2014
Notch signaling: switching an oncogene to a tumor suppressorCamille Lobry, Philmo Oh, Marc R Mansour, et al.
Leukemia|November 18, 2023
Monitoring clone dynamics and reversibility in clonal haematopoiesis and myelodysplastic neoplasm associated with PARP inhibitor therapy-a role for early monitoring and interventionEllen Nuttall Musson, Rowan E Miller, Marc R Mansour, et al.
Pageof 7